Endocrinology
News
AHA: Physical activity best first-line for high BP, cholesterol
Advice to sit less and move more is a critical component of first-line treatment for patients with mild to moderate hypertension and elevated...
From the Journals
Waist circumference a marker for NAFL in type 1 diabetes
A cross-sectional study has found that waist-to-height ratio is a sensitive marker for nonalcoholic fatty liver in type 1 diabetes.
Conference Coverage
‘Remarkable’ response to diabetes drug in resistant bipolar depression
Patients with treatment-resistant bipolar depression with insulin resistance showed marked improvement in depressive symptoms after metformin...
From the Journals
A1c below prediabetes cutoff linked to subclinical atherosclerosis
Hemoglobin A1c below prediabetes levels is a potential biomarker for subclinical atherosclerosis, a European observational study reports.
Conference Coverage
Prediabetes linked to higher CVD and CKD rates
Data from more than 330,000 U.K. adults show that an A1c of 5.7%-6.4% links with higher rates of incident CKD and CVD events.
Conference Coverage
‘A better picture’: First AACE guidelines on diabetes technology
Current knowledge on insulin pumps, continuous glucose monitors, automated insulin delivery systems, ‘smart’ pens, telemedicine, apps, and...
Conference Coverage
Daily cup of coffee cuts type 2 diabetes risk by about 5%
Beneficial effects may be caused by coffee’s ability to reduce inflammation.
Conference Coverage
Sotagliflozin’s HFpEF benefit confirmed by new analyses
Conference Coverage
FIDELIO-DKD: Finerenone cuts new-onset AFib in patients with type 2 diabetes and CKD
Conference Coverage
Dapagliflozin misses as treatment for COVID-19 but leaves intriguing signal for benefit
The SGLT2 inhibitor dapagliflozin was not associated with significant benefit in COVID-19 patients but came close.
From the Journals
Doctors prescribe fewer statins in the afternoon